SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Sanara MedTech Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$33.14−0.02 (-0.06%)
Close on Oct 19, 2026
- Market cap
- $287.08M
- P/E (TTM)
- –
- Dividend yield
- –
Sanara MedTech statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Orthopedic, Prosthetic & Surgical Appliances & Supplies companies for comparison
Valuation
| Measure | Sanara MedTech | Industry median |
|---|---|---|
| Market Cap | $304.49M | $230.55M |
| Enterprise Value | $335.54M | $202.97M |
| PS Ratio | 2.77 | 3.11 |
| PB Ratio | 38.33 | 3.14 |
| P/FCF Ratio | 67.61 | 27.25 |
| P/OCF Ratio | 53.47 | 22.35 |
Enterprise value
| Measure | Sanara MedTech | Industry median |
|---|---|---|
| EV / Sales | 3.06 | 2.92 |
| EV / EBITDA | 30.77 | 19.86 |
| EV / EBIT | 39.86 | 24.88 |
| EV / FCF | 74.50 | 27.85 |
Income (trailing twelve months)
| Measure | Sanara MedTech | Industry median |
|---|---|---|
| Revenue | $109.82M | $102.39M |
| Gross Profit | $102.16M | $60.36M |
| Operating Income | $8.42M | -$4.31M |
| Net Income | -$32.02M | -$6.57M |
| EBITDA | $10.90M | -$1.98M |
| EPS (Diluted) | -$3.61 | -$0.07 |
Margins
| Measure | Sanara MedTech | Industry median |
|---|---|---|
| Gross Margin | 93.0% | 55.1% |
| Operating Margin | 7.67% | -6.04% |
| Profit Margin | -29.2% | -10.5% |
| EBITDA Margin | 9.93% | -2.67% |
| FCF Margin | 4.10% | -0.30% |
Returns
| Measure | Sanara MedTech | Industry median |
|---|---|---|
| Return on Equity (ROE) | -147.7% | -19.2% |
| Return on Assets (ROA) | -38.1% | -13.3% |
| Return on Invested Capital (ROIC) | 13.1% | -4.11% |
| Return on Capital Employed (ROCE) | 14.9% | -9.07% |
Growth
| Measure | Sanara MedTech | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 13.0% | 8.85% |
| FCF Growth (YoY) | 5368.1% | 10.6% |
| Revenue Growth (3Y CAGR) | 31.0% | 7.08% |
| Revenue Growth (5Y CAGR) | 45.9% | 11.8% |
Balance sheet
| Measure | Sanara MedTech | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $15.42M | $37.33M |
| Total Debt | $46.48M | $72.66M |
| Net Cash (Debt) | -$31.06M | $3.92M |
| Net Cash Per Share | -$3.38 | $0.28 |
| Equity (Book Value) | $7.94M | $57.36M |
| Book Value Per Share | $0.86 | $2.81 |
| Tangible Book Value | -$12.94M | $10.71M |
| Working Capital | $19.71M | $54.64M |
Financial position
| Measure | Sanara MedTech | Industry median |
|---|---|---|
| Current Ratio | 2.58 | 2.50 |
| Quick Ratio | 2.24 | 1.54 |
| Debt / Equity | 5.85 | 0.38 |
| Debt / EBITDA | 4.26 | 2.31 |
| Debt / FCF | 10.32 | 3.50 |
| Net Debt / EBITDA | 2.85 | 1.53 |
| Interest Coverage | 1.16 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Sanara MedTech | Industry median |
|---|---|---|
| Operating Cash Flow | $5.69M | -$653.46K |
| Capital Expenditures | -$1.19M | -$3.69M |
| Free Cash Flow | $4.50M | -$835.02K |
| FCF Per Share | $0.49 | -$0.02 |
Efficiency
| Measure | Sanara MedTech | Industry median |
|---|---|---|
| Asset Turnover | 1.31 | 0.59 |
| Inventory Turnover | 2.20 | 2.21 |
| Revenue Per Employee | $1.02M | $322.57K |
| Profits Per Employee | -$296.44K | -$51.88K |
| Employee Count | 108 | 185 |
Dividends and yields
| Measure | Sanara MedTech | Industry median |
|---|---|---|
| Earnings Yield | -10.5% | -6.91% |
| FCF Yield | 1.48% | -0.56% |
Shares
| Measure | Sanara MedTech | Industry median |
|---|---|---|
| Shares Outstanding | 9,188,040 | 44,856,700 |
| Shares Change (YoY) | -0.54% | 3.35% |
| Shares Change (QoQ) | 0.31% | 0.27% |
| Float | 7,822,180 | 37,097,900 |
| Shares Held by Insiders | 14.9% | 10.6% |
| Shares Held by Institutions | 19.4% | 63.5% |
Scores
| Measure | Sanara MedTech | Industry median |
|---|---|---|
| Altman Z-Score | 3.80 | 1.95 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from Sanara MedTech's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.